Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma.
Purpose: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [18F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. Methods: Twenty-five patients with sta...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 48; no. 6; pp. 1932 - 1944 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |